Neoplasms Metastasis Completed Phase 2 / 3 Trials for Docetaxel (DB01248)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00401323Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaTreatment